BamSEC and AlphaSense Join Forces
Learn More

Cue Biopharma Inc. – Underwriting Agreements

NASDAQ: CUE    
Share price (7/2/26): $28.26    
Market cap (7/2/26): $119 million

Underwriting Agreements Filter

EX-1.1
from 8-K 39 pages Cue Biopharma, Inc. (A Delaware Corporation) 12,500,000 Shares of Common Stock Pre-Funded Warrants to Purchase Up to 23,214,286 Shares of Common Stock Common Stock Warrants to Purchase Up to 17,857,143 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 38 pages Cue Biopharma, Inc. (A Delaware Corporation) 13,530,780 Shares of Common Stock Pre-Funded Warrants to Purchase Up to 11,469,216 Shares of Common Stock Warrants to Purchase Up to 6,249,999 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 37 pages Cue Biopharma, Inc. (A Delaware Corporation) 11,564,401 Shares of Common Stock Pre-Funded Warrants to Purchase Up to 12,435,599 Shares of Common Stock Warrants to Purchase Up to 6,000,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 40 pages Open Market Sale Agreementsm
12/34/56
EX-1.1
from 8-K 25 pages Cue Biopharma, Inc. Common Stock ($0.001 Par Value Per Share) At-The-Market Equity Offering Sales Agreement
12/34/56
EX-1.1
from 8-K 25 pages Cue Biopharma, Inc. Common Stock ($0.001 Par Value Per Share) At-The-Market Equity Offering Sales Agreement
12/34/56
EX-1.1
from 8-K 25 pages Cue Biopharma, Inc. Common Stock ($0.001 Par Value Per Share) At-The-Market Equity Offering Sales Agreement
12/34/56
EX-1.1
from 8-K 25 pages Cue Biopharma, Inc. Common Stock ($0.001 Par Value Per Share) At-The-Market Equity Offering Sales Agreement
12/34/56
EX-1.1
from S-1/A 29 pages Cue Biopharma, Inc. Underwriting Agreement
12/34/56